Copyright investors
In a welcome move, NOV (NOV) saw its Relative Strength Rating rise from 66 to 74 on Tuesday. IBD's unique RS Rating tracks technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the trailing 52 weeks compares to other publicly traded companies. Decades of market research shows that the best-performing stocks tend to have an 80 or higher RS Rating in the early stages of their moves. See if NOV can continue to rebound and clear that threshold. NOV is not currently near a potential buying area. See if the stock goes on to form a promising consolidation that could launch a new move. NOV reported negative growth for both the top and bottom lines last quarter. NOV earns the No. 9 rank among its peers in the Oil & Gas-Machinery/Equipment industry group. Archrock (AROC), Enerflex (EFXT) and TechnipFMC (FTI) are among the top 5 highly rated stocks within the group. This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
